News
Market
Jobs
About
Contact
List Product
Register
Login
Generate
WhatsApp Message
*Zimbabwe in new HIV prevention study* *Follow Pindula on WhatsApp for daily new updates* https://whatsapp.com/channel/0029Va84dngJP21B2nWeyM3v?qx Zimbabwe has embarked on a new HIV study aimed at assessing if antibodies can be used to prevent contracting HIV from an infected partner if infused directly to a participant. In this latest study known as Antibody Mediated Prevention (AMP), scientists have manufactured an antibody called VRC01 which will be infused in human participants through intravenous(IV) fluid, popularly known as drip, once after every 8 weeks for two years. In an interview during the AMP study update meeting in Cape Town, South Africa, protocol co-chairperson Dr Nyaradzo Mgodi said the process is similar to how vaccines for polio and chicken pox were developed. ---------- *HOT DEALS:* *itel A70 - (128GB, 3GB RAM) $89,* *itel A70 - (256GB, 4GB RAM) $99* *itel P40 (128GB, 4GB), (6000mAh) $99* *itel P40 (64GB, 4G), (6000mAh) $93* Cash on Delivery in Harare & Bulawayo. Tinotumira kwamuri inosvika. WhatsApp: 0️⃣7️⃣8️⃣3️⃣ 4️⃣5️⃣0️⃣ 7️⃣9️⃣3️⃣ ---------- Mgodi said so far 61 women had volunteered to take part in the study in Zimbabwe against a target of 261. The study will take place at Harare (Spillhaus Clinic) and Chitungwiza (Seke South Clinic). The study is being conducted in Botswana, Tanzania, Mozambique, Malawi, Kenya and South Africa. 1 500 women are expected to participate in the study. More: Herald _If you found this article useful_ *Please support Pindula by forwarding to friends and groups*
Copy to clipboard
Give us Feedback
Full Name
WhatsApp Number
Feedback
Submit
Feedback